Universal Biosensors lodges prospectus for A$10M entitlement offer

Universal Biosensors, Inc. (ASX: $UBI) has lodged a transaction specific prospectus with the Australian Securities and Investments Commission and ASX for a fully underwritten pro-rata non-renounceable rights issue of CHESS depositary interests over new fully paid shares of common stock to raise approximately A$10 million, along with an offer of options. The Entitlement Offer opens on Friday, 19 April 2024 and is expected to close at 5.00pm (AEDT) on Wednesday, 1 May 2024.

Executive Commentary on Entitlement Offer and Options Prospectus

The Company is pleased to announce the lodging of the prospectus for the A$10 million entitlement offer and options. This capital raise will support our ongoing efforts to build a multi-product stable of biosensors in large markets, generating ongoing revenue streams. We encourage eligible securityholders to carefully review the prospectus for further details about the Entitlement Offer and consider participating in this opportunity.

Summary of Universal Biosensors' Entitlement Offer and Options Prospectus

Universal Biosensors, Inc. (ASX: $UBI) has lodged a prospectus for a fully underwritten pro-rata non-renounceable rights issue of CHESS depositary interests to raise approximately A$10 million, along with an offer of options. The Entitlement Offer opens on Friday, 19 April 2024 and is expected to close at 5.00pm (AEDT) on Wednesday, 1 May 2024. The Company's ambition is to build a multi-product stable of biosensors in large markets, generating ongoing revenue streams. Eligible securityholders are encouraged to carefully review the prospectus for further details about the Entitlement Offer and consider participating in this opportunity.